Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise and Acarbose in Type 2 Diabetes
NCT01244971Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Jan 2004
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acarbose in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Karolinska Institutet. Primary endpoint: Glycemic control at 12 weeks. Started Jan 2004; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01244971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244971.